TH17 cells release IL-17A at the site of inflammation, leading to an increase in pro-inflammatory cytokines as well as antimicrobial peptides such as β-defensin-256,57, thereby supporting early protective immune responses necessary to combat bacterial infections. This evidence concerns the gene IL17A and bacterial infectious disease.